logo
welcome
Reuters

Reuters

Exclusive-US FDA finds widely used asthma drug impacts the brain

Reuters
Summary
Nutrition label

78% Informative

Singulair was a blockbuster product for Merck after its launch in 1998 , offering relief in a pill as an alternative to an inhaler.

By 2019 , thousands of reports of neuropsychiatric episodes, including dozens of suicides, in patients prescribed the drug had piled up on internet forums and in the U.S. Food and Drug Administration’s tracking system.

VR Score

88

Informative language

94

Neutral language

60

Article tone

formal

Language

English

Language complexity

61

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links